SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,810.00    115.00 (1.72%)
Bid:
6,770.00
Ask:
6,775.00
Spread: 5.00 (0.074%)
Market Cap: £5.03b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Trading update

6 Jul 2010 07:00

RNS Number : 8527O
Spirax-Sarco Engineering PLC
06 July 2010
 



 

Spirax-Sarco Engineering plc

Tuesday 6th July 2010

 

TRADING UPDATE

 

 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following update in respect of its trading for the six months ended 30th June 2010. Results for the first half-year are expected to be announced on 24th August 2010.

 

Since the AGM, trading conditions continue to be positive and sales for the first half-year were ahead 8% at constant currency, including a 2% contribution from acquisitions; also, the order book increased. Growth continues to be led by Watson-Marlow Pumps and in the steam business by the Americas and Asia Pacific, with EMEA mixed but overall flat. Exchange movements have been favourable and added 2% to sales on translation in the first half-year versus average exchange rates in the comparable period last year.

 

Adjusted operating profit margin1 shows a strong improvement over the 15.0% in the first half of 2009 and is expected to be above 19% for the first half of 2010. We have benefited from operational gearing from the increase in sales, last year's cost reduction measures, small exchange gains and a favourable product mix. Material costs have also been favourable but are rising and we anticipate this impacting the second half of the year. We are also increasing our investment in new product development and in market development to enhance our future growth prospects.

 

We continue to operate with a strong balance sheet and net cash balances at 30th June 2010 were £18m. As we have previously indicated, capital investment for this year is expected to be at a high level as we progress several major manufacturing projects, including our new plant in China that was opened last week and the consolidation onto one manufacturing site in Cheltenham.

 

 

1 The adjusted operating profit margin noted above excludes the amortisation of acquisition-related intangible assets and an £8m exceptional revaluation gain following the 25th May 2010 acquisition of our partners' 51% shareholding in our Mexican business.

 

 

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535234

 

 

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and peristaltic pumping. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,200 people, of whom 1,200 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKKPDBABKDBOK
Date   Source Headline
25th May 201210:00 amRNSResult of AGM
22nd May 20123:20 pmRNSDirector/PDMR Shareholding
16th May 20124:45 pmRNSRe-Appointment of Non-Executive Directors
16th May 20129:13 amRNSHolding(s) in Company
15th May 20127:00 amRNSInterim Management Statement
10th May 20123:01 pmRNSHolding(s) in Company
9th May 20129:57 amRNSHolding(s) in Company
1st May 20125:03 pmRNSTotal Voting Rights
26th Apr 20123:02 pmRNSDirector/PDMR Shareholding
23rd Apr 20128:41 amRNSHolding(s) in Company
17th Apr 20122:56 pmRNSDirector/PDMR Shareholding
17th Apr 20122:14 pmRNSDirector/PDMR Shareholding
12th Apr 20128:33 amRNSHolding(s) in Company
2nd Apr 201210:05 amRNSHolding(s) in Company
27th Mar 201210:44 amRNSHolding(s) in Company
20th Mar 20125:16 pmRNSHolding(s) in Company
15th Mar 201211:00 amRNSDirector/PDMR Shareholding
15th Mar 20127:00 amRNSDirectorate Change
14th Mar 20125:17 pmRNSDirector/PDMR Shareholding
8th Mar 20127:00 amRNSPreliminary Results
1st Mar 201210:38 amRNSTotal Voting Rights
22nd Feb 20129:11 amRNSHolding(s) in Company
16th Feb 20129:09 amRNSHolding(s) in Company
8th Feb 20128:39 amRNSHolding(s) in Company
1st Feb 20121:39 pmRNSTotal Voting Rights
16th Jan 20124:49 pmRNSNotice of Results
3rd Jan 20128:53 amRNSTotal Voting Rights
19th Dec 20119:11 amRNSRe-Appointment of Non-Executive Director
12th Dec 20114:25 pmRNSDirector/PDMR Shareholding
16th Nov 20115:31 pmRNSDirector/PDMR Shareholding
4th Nov 20117:00 amRNSInterim Management Statement
1st Nov 20114:27 pmRNSTotal Voting Rights
19th Oct 201112:00 pmRNSDirectorate Change
18th Oct 20119:28 amRNSHolding(s) in Company
17th Oct 20111:58 pmRNSHolding(s) in Company
12th Oct 20113:51 pmRNSDirector/PDMR Shareholding
11th Oct 20114:15 pmRNSTotal Voting Rights
6th Sep 20119:00 amRNSTotal Voting Rights
5th Sep 20115:02 pmRNSDirector/PDMR Shareholding
24th Aug 20114:28 pmRNSDirector/PDMR Shareholding
23rd Aug 20113:54 pmRNSDirector/PDMR Shareholding
23rd Aug 20117:00 amRNS2011 Half Year Results
4th Aug 20115:32 pmRNSNotice of Results
4th Aug 20114:11 pmRNSTotal Voting Rights
27th Jul 20111:03 pmRNSAdditional Listing
12th Jul 20115:14 pmRNSDirector/PDMR Shareholding
6th Jul 20111:47 pmRNSAdditional Listing
1st Jul 201110:43 amRNSTotal Voting Rights
22nd Jun 20114:05 pmRNSDirector/PDMR Shareholding
9th Jun 20119:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.